celecoxib has been researched along with Carcinoma in Situ in 3 studies
Carcinoma in Situ: A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celecoxib is a nonsteroidal anti-inflammatory drug that selectively inhibits COX-2." | 1.36 | Cyclooxygenase-2 inhibition for the prophylaxis and treatment of preinvasive breast cancer in a her-2/neu mouse model. ( Buttars, S; Done, SJ; Tran-Thanh, D; Wen, Y; Wilson, C, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Woditschka, S | 1 |
| Haag, JD | 1 |
| Sullivan, R | 1 |
| Gould, MN | 1 |
| Tran-Thanh, D | 1 |
| Buttars, S | 1 |
| Wen, Y | 1 |
| Wilson, C | 1 |
| Done, SJ | 1 |
| Bundred, NJ | 1 |
| Cramer, A | 1 |
| Morris, J | 1 |
| Renshaw, L | 1 |
| Cheung, KL | 1 |
| Flint, P | 1 |
| Johnson, R | 1 |
| Young, O | 1 |
| Landberg, G | 1 |
| Grassby, S | 1 |
| Turner, L | 1 |
| Baildam, A | 1 |
| Barr, L | 1 |
| Dixon, JM | 1 |
1 trial available for celecoxib and Carcinoma in Situ
| Article | Year |
|---|---|
Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled trial.
Topics: Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aromatase Inhibitors; Bre | 2010 |
2 other studies available for celecoxib and Carcinoma in Situ
| Article | Year |
|---|---|
A short-term rat mammary carcinogenesis model for the prevention of hormonally responsive and nonresponsive in situ carcinomas.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Bexarotene; Carcinoma | 2009 |
Cyclooxygenase-2 inhibition for the prophylaxis and treatment of preinvasive breast cancer in a her-2/neu mouse model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, B | 2010 |